Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online May 17, 2007
OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow Full Text (PDF)
Right arrowOA All Versions of this Article:
2007-0057v1
25/8/1853    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drummond, M. W
Right arrow Articles by Brummendorf, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drummond, M. W
Right arrow Articles by Brummendorf, T. H.
Submitted on January 22, 2007
Accepted on April 9, 2007

CANCER STEM CELLS

Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells

Mark W Drummond 1*, Stefan Balabanov 2, Tessa L Holyoake 3, Tim H. Brummendorf 2

1 Department of Haematology, Western Infirmary, Glasgow G11 6NT, UK
2 Dept. of Oncology and Hematology, University Medical Center Eppendorf, Hamburg, Germany
3 Section of Experimental Hematology, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, UK

* To whom correspondence should be addressed. E-mail: mark.drummond{at}northglasgow.scot.nhs.uk.


   Abstract

The measurement of telomere length can give an insight into the replicative history of the cells in question. Much of the observed telomere loss occurs at the stem and progenitor cell level even though these populations express the enzyme telomerase. Telomerase transfected hematopoietic stem cells (HSC), although able to maintain telomere length, are still limited in terms of ability to undergo sequential transplantation, and other factors require to be addressed to achieve optimal levels of stem cell expansion. Unchecked telomere loss by HSC meanwhile, would appear to play a significant role in the pathogenesis of bone marrow failure, as observed in the condition Dyskeratosis Congenita (DKC). This heterogeneous inherited condition appears to exhibit telomerase dysfunction as a common final pathogenic mechanism. While less well established for acquired marrow failure syndromes, mutations in key telomerase components have been described. The identification of the leukemic stem cell (LSC) along with the desire to target this population with anti-leukemia therapy demands that telomerase biology be fully understood in this cell compartment. Future studies utilizing primary selected LSC-rich samples are required. A better understanding of telomerase regulation in this population may allow effective targeting of the telomerase enzyme complex using small molecule inhibitors or additional novel approaches.

Key Words. Telomere, Telomerase, stem cell, ageing, leukemia, bone marrow failure




This article has been cited by other articles:


Home page
Mol Biol EvolHome page
M. F. Haussmann and R. A. Mauck
Telomeres and Longevity: Testing an Evolutionary Hypothesis
Mol. Biol. Evol., January 1, 2008; 25(1): 220 - 228.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.